NFKB1 and breast cancer: Interestingly, JSH-23 (±PEDF) treatment increased MCF-7 viability under post-menopausal oestrogen conditions, which may be related to time-dependent effects of NFκB-mediated regulation of BC cell proliferation and apoptosis in the presence of oestrogen.